🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nana-Ama A.S. Anang

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-8495-2978
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention”.

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0856
N/A
0DataRank · unranked
278 citations

Wouter C. Meijers, Margaret L. Axelrod, Nana-Ama A.S. Anang, Elles M. Screever, Elizabeth C. Wescott +22 more

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Nature Communications(2022)10.1038/s41467-022-31941-w
N/A
0DataRank · unranked
176 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen +17 more

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.01.478744
N/A
0DataRank · unranked
9 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Nana-Ama A.S. Anang +16 more

Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2418985122
N/A
0DataRank · unranked
24 citations

Huey Liu, Didem Ağaç Çobanoğlu, Nana-Ama A.S. Anang, James J. Mancuso, E. John Wherry +2 more